-

Blackstone Announces 1-Year Anniversary for BCRED, Surpasses $32.6 Billion in Portfolio Assets

$15.8 billion in investor capital raised since inception

NEW YORK--(BUSINESS WIRE)--Blackstone today announced that Blackstone Private Credit Fund (BCRED), its newest perpetual private credit strategy, has completed its inaugural full year of operations.

Joan Solotar, Global Head of Private Wealth Solutions at Blackstone, said: “We launched BCRED last year with the goal of redefining the way income-focused individual investors calibrate their fixed income portfolios. Five years ago, we structured BREIT, our non-traded REIT, with a similar vision – and we believe the incredible growth and investor reception of both platforms mark a significant sea change in the opportunity set for alternatives.”

BCRED was introduced in January 2021 as a perpetual business development company (BDC), modeled after Blackstone’s private real estate product, BREIT. BCRED is part of Blackstone’s $63 billion direct lending business, which is a leader in the market’s shift of large-scale debt financings from the public syndicated to the private credit market. In 2021, Blackstone Credit participated in 19 direct lending deals over $1 billion, including investments in Auctane (formerly Stamps.com), one of the largest new direct loans ever carried out in private markets, and Inovalon, where Blackstone Credit supported one of the largest healthcare software take-private deals in history.

Brad Marshall, Blackstone’s Head of North of America Private Credit and CEO of BCRED, said: “Blackstone’s scale and expertise enabled us in one year to build a large, high-quality portfolio of floating rate, senior loans and we believe we are well positioned for what could be an inflationary, rising rate environment. We are seeing a meaningful secular shift toward private credit and are energized by the opportunity to bring our scale and efficient, tailored solutions to even more private businesses and sponsors.”

About Blackstone Private Credit Fund

Blackstone Private Credit Fund (BCRED) is a perpetual-life, institutional quality investment platform that brings private credit to income focused investors. BCRED invests primarily in the debt of private U.S. companies through first lien senior secured loans and is externally managed by a subsidiary of Blackstone (NYSE: BX). Blackstone Credit is one of the world’s largest credit-focused asset managers, with $243 billion in investor capital under management. Further information is available at www.bcred.com.

About Blackstone

Blackstone is the world’s largest alternative asset manager. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $881 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, Twitter, and Instagram.

Contacts

Mariel Seidman-Gati
Mariel.seidmangati@blackstone.com
+1 917-698-1674

Blackstone

NYSE:BX

Release Versions

Contacts

Mariel Seidman-Gati
Mariel.seidmangati@blackstone.com
+1 917-698-1674

More News From Blackstone

Blackstone Real Estate Debt Strategies Launches Homebuilder Lending Platform

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) today announced that Blackstone Real Estate Debt Strategies (“BREDS”) has launched a lending platform that will provide much needed capital and flexibility to homebuilders, and expects to enable the construction of over 50,000 for-sale homes across the United States annually. This lending platform is supported by BREDS portfolio company, Brio Homebuilder Solutions, as well as partnerships with third parties. This commitment comes at a time when t...

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency

NEW YORK & NATICK, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $250 million investment in Anagram Therapeutics (“Anagram”), a clinical-stage private biopharmaceutical company dedicated to improving the lives of people living with exocrine pancreatic insufficiency due to cystic fibrosis (“CF”), pancreatic cancer and related disorders. The investment will help fund the further development, approval and launch of Anagram’s ANG003, a novel orally delivered recombinan...

Anthropic Partners with Blackstone, Hellman & Friedman, and Goldman Sachs to Launch Enterprise AI Services Firm

SAN FRANCISCO--(BUSINESS WIRE)--Anthropic, Blackstone, Hellman & Friedman, and Goldman Sachs today announced the formation of a new AI-native enterprise services firm that will work with companies to rapidly bring Claude into their core business operations. The new firm is a standalone entity with Anthropic engineering and partnership resources embedded directly within its team. Alongside the founding partners, the new company is backed by a consortium of leading alternative asset managers...
Back to Newsroom